Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (7 ops.)
Latest filing published 22 Sept 2026 for Coca-Cola HBC AG, €179k. Read the official filing
Filing timeline
BuySalePanagiota Kalogeraki
Insider track record
Disclosed buys
1
Disclosed sells
7
Signal history
Closed purchases
Market purchases
51
Positive at T+90
25%
Median T+90
-3.6%
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -5.8%Entry £45.44 · Close 09 Oct 2026 £42.82
- -3.6%Entry £44.42 · Close 09 Oct 2026 £42.82
- -4.7%Entry £48.16 · Close at T+30 £45.92
- -13.8%Entry £49.70 · Close 09 Oct 2026 £42.82
- -6.8%Entry £45.94 · Close 09 Oct 2026 £42.82
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Panagiota Kalogeraki: trading record in brief
Panagiota Kalogeraki is a declared insider of Coca-Cola HBC AG, with filings sourced from RNS (LSE). In total, 62 filings cover trades dated from 16 June 2023 to 21 September 2026.
In open-market terms, that means 1 purchase worth €179k on one side and 7 sales worth €8.3M on the other. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 54 share grants. So far in 2026, the count stands at 1 purchase and 2 sales.
After 4 purchases with a full 90-day history, the hit rate stands at 25% and the median 90-day move at -3.6%. This is a record of the past, not a forecast.
Most recently, on 22 September 2026, the filings show an open-market purchase worth €179k in Coca-Cola HBC AG. Filings reach the RNS (LSE) feed a median of 1 day after the trade. The legal deadline for notifying a trade is three business days (UK MAR). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Panagiota Kalogeraki
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations62 total
3,600 shares@ £42.71540.0010% mcap1.2% of flowXLONISIN CH0198251305FCA-NSM:4804fefb-b3ba-4d1d-bac4-a69d6f30271b
Canonical exit: 20 Dec 2026 (T+90)
6,135.43 shares@ £79.11730.0030% mcap18.9% of flowXLONISIN CH0198251305RNS:9780295-3
Canonical exit: 16 Dec 2026 (T+90)
95.41 shares@ £46.57120.0000% mcap0.2% of flowXLONISIN CH0198251305FCA-NSM:960d7afd-62bb-4960-97fb-623cbb854d43-3
Canonical exit: 16 Dec 2026 (T+90)
5,801.33 shares@ £74.56030.0027% mcap16.9% of flowXLONISIN CH0198251305RNS:9728222-3
Canonical exit: 15 Nov 2026 (T+90)
90.002 shares@ £45.52920.0000% mcap0.2% of flowXLONISIN CH0198251305FCA-NSM:a56dbc51-4cd1-4d4d-9192-e2095a1dd404-3
Canonical exit: 15 Nov 2026 (T+90)
28,000 shares@ £49.59720.0087% mcap11.0% of flowXLONISIN CH0198251305FCA-NSM:bcbad2d8-25bf-46ad-8b82-16aae1928178
5,824.84 shares@ £68.58930.0025% mcap15.7% of flowXLONISIN CH0198251305RNS:9678059-3
Canonical exit: 15 Oct 2026 (T+90)
82.794 shares@ £49.64490.0000% mcap0.2% of flowXLONISIN CH0198251305FCA-NSM:42e3aacf-a69b-40c3-ad73-57773f9de9e7-3
Canonical exit: 15 Oct 2026 (T+90)
6,206.49 shares@ £80.20840.0034% mcap19.2% of flowXLONISIN CH0198251305RNS:9626124-3
Canonical exit: 15 Sept 2026 (T+90)
0XLONRNS:c429fc9a-8344-4620-bfca-ad06273394fc-3
Canonical exit: 15 Sept 2026 (T+90)
9,140.004 shares@ £44.76060.0028% mcap15.8% of flowXLONISIN CH0198251305RNS:9619208-5
Canonical exit: 9 Sept 2026 (T+90)
0XLONRNS:9f0bc752-7a6b-44e3-99d8-0fff20d2763f-5
Canonical exit: 9 Sept 2026 (T+90)
5,649.02 shares@ £61.582513.4% of flowXLONISIN CH0198251305RNS:9576123-3
Canonical exit: 16 Aug 2026 (T+90)
0XLONRNS:cfd77d8b-474a-4838-9d16-8d9b51a277e7-3
Canonical exit: 16 Aug 2026 (T+90)
0XLONRNS:e4673e71-fc27-4c38-a628-cfae4bc8b9f0-3
Canonical exit: 16 Jul 2026 (T+90)
50,132 shares@ £42.8160.015% mcap16.9% of flowXLONISIN CH0198251305RNS:28e99025-53fc-41b3-a1c5-717a297ea0ba-4
39,626 shares@ £44.620.012% mcap14.0% of flowOUTSIDE A TRADING VENUEISIN CH0198251305RNS:40364c27-a273-467d-9ce9-318f08b0bde1-3
0XLONRNS:b03dfd59-a0d2-4314-b28e-17fab2efb035-4
Canonical exit: 15 Jun 2026 (T+90)
0XLONRNS:c6180186-6052-45b4-a644-171ed0251413-4
Canonical exit: 18 May 2026 (T+90)
25,000 shares@ £46.609.1% of flowXLONISIN CH0198251305RNS:41a12b33-fd09-4d5f-97e4-949c4e71450f
Canonical exit: 17 May 2026 (T+90)
0XLONRNS:0b7e599b-e57b-4444-848c-34eae4c62517-5
Canonical exit: 16 Apr 2026 (T+90)
0OUTSIDE A TRADING VENUEISIN CH0198251305RNS:0df6fe0b-9396-4d3e-a26f-060cd77685e4
0XLONRNS:cf30e649-c5b6-41d8-9999-457b30522a78-5
Canonical exit: 17 Mar 2026 (T+90)
0XLONISIN CH0198251305RNS:5868283-5
Canonical exit: 15 Jan 2026 (T+90)
0XLONISIN CH0198251305RNS:5826797-5
Canonical exit: 16 Dec 2025 (T+90)
25 of 62 declarations
